# NEXTPHARMA DRUG — NAFDAC-Registered Products & Company Profile

NEXTPHARMA DRUG holds 6 active NAFDAC product registrations in our October 2026 copy of the Greenbook.

- Source: https://ogbogwu.com/manufacturers/nextpharma-drug/
- NAFDAC-registered products: 6 · Pain & Fever, Antimalarials, Respiratory
- Made in: India (5), China (1)
- Address & phone: Not on record — the NAFDAC Greenbook lists products, not offices.
- Rank by registered products: 306 of 533 manufacturers tracked (October 2026 copy)
- Nigerian company: no

## Register profile (October 2026 copy)

NEXTPHARMA DRUG has 6 products registered with NAFDAC for the Nigerian market in our October 2026 copy of the Greenbook. The full list below is compiled from that copy of the NAFDAC Greenbook — Nigeria's official register of approved products.
Its medicines are strongest in Pain & Fever (4 products), Antimalarials (1 product) and Respiratory (1 product). Registered brands include BUDEX Tablet and Pregabalin Capsules 150 mg. Most of its products are registered as capsule, tablet and injection formulations. 6 of its products link through to full Ogbogwu drug guides covering uses, dosage, prices, and NAFDAC verification. NEXTPHARMA DRUG is the registration holder rather than the physical maker: the Greenbook records factories abroad for its products (mostly India).

## Product categories (October 2026 copy)

- Pain & Fever: 4 products
- Antimalarials: 1 product
- Respiratory: 1 product

## Registered products in our October 2026 copy

| Product | NAFDAC Reg. No. | Strength | Form |
|---|---|---|---|
| Artemether & Lumefantrine Tablet | B4-7772 | 80 mg; 480 mg | Tablet |
| BUDEX Tablet | B4-6678 | 0.5 mg | Tablet |
| Next Pharm Pentazocine Injection 30mg/ml | A4-101685 | 30mg/ml | Injection |
| Pregabalin Capsules 150 mg | A4-101732 | 150 mg | Capsule |
| Pregabalin Capsules 300 mg | A4-101731 | 300 mg | Capsule |
| Pregabalin Capsules 75 mg | A4-101730 | 75 mg | Capsule |

Verify any NAFDAC number free: https://ogbogwu.com/nafdac-checker/